In colorectal cancer patients, those with low levels of CD8+ T cell infiltration have significantly shorter OS compared to those with high levels (P = 0.01) (43), and the absence of CD8+ T cell infiltration contributes to immune resistance (44). This evidence concerns the gene CD8A and colorectal cancer.